Product may contain the incorrect material which could impact treatment.
Source facts
Action
Customer notification began August 8, 2022. The responsible Johnson & Johnson affiliates in Japan will be contacting all their impacted primary and secondary consignees and/or end customers.
Customers are asked to immediately check inventory for impacted product and to quarantine that product. In the event product has been forwarded to another facility, the customer shall contact that facility to arrange return. The customer shall complete the Business Reply Form (BRF) to confirm receipt of the recall notice within 3 business days. Customers are required to return unused impacted product per the recall letter instructions.
Initiated
2022-08-08
Root cause
Process control
Distribution
Distribution in Japan only
Recall number
Z-1773-2022
Recall status
Open, Classified
CDRH record ID
195686
FDA record created
2022-09-20
Recall event number
90764
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.